UnitedHealth Group revealed Thursday it is facing Department of Justice investigations implicit its Medicare billing practices, adding to a drawstring of setbacks for a institution that owns the nation's largest and astir almighty backstage insurer.
In a securities filing, the institution said that it has started complying with ceremonial transgression and civilian requests from the DOJ, and that it reached retired to the section aft reports of the probes surfaced. UnitedHealth besides said it has launched a third-party reappraisal of its concern policies and show metrics.
The institution told CNBC that it expects to implicit that reappraisal toward the extremity of the 3rd quarter.
In the filing, UnitedHealth said it "has afloat assurance successful its practices and is committed to moving cooperatively with the Department passim this process."
UnitedHealth Group shares dropped astir 2% connected Thursday. The company's executives volition apt look questions astir the probe during its second-quarter net telephone connected July 29.
Jared Holz, Mizuho Securities health-care strategist, said successful an email to clients connected Thursday that the announcement is "not shocking," but noted that the institution antecedently denied DOJ probe claims. He said UnitedHealth's determination to admit to the probes and cooperate with the section "all sounds logical arsenic it moves guardant with a caller CEO."
The institution announced the abrupt departure of erstwhile CEO Andrew Witty successful May.
UnitedHealth's announcement connected Thursday comes aft The Wall Street Journal reported in May that the Department of Justice is conducting a transgression probe into the health-care elephantine implicit imaginable Medicare fraud. In effect astatine the time, the institution said it stands "by the integrity of our Medicare Advantage program."
In July, the Journal also reported that the DOJ interviewed respective doctors astir UnitedHealth's practices and whether they felt pressured to taxable claims for definite conditions that bolstered payments from the Medicare Advantage programme to the company.
That marked the 2nd clip this twelvemonth that the insurer's Medicare Advantage concern has travel nether national scrutiny. The Journal besides reported successful February that the DOJ is conducting a civilian probe into whether the institution inflated diagnoses to trigger other payments to its Medicare Advantage plans.
But connected Thursday, UnitedHealth said autarkic audits by the Centers for Medicare and Medicaid Services "confirm" that the company's practices are "among the astir close successful the industry."
More CNBC wellness coverage
UnitedHealth besides pointed to a peculiar master's proposal successful March successful favour of the institution successful a yearslong ineligible conflict with the DOJ that began with a whistleblower who alleged the institution illegally withheld astatine slightest $2 cardinal done the Medicare Advantage program. The peculiar maestro assigned to the lawsuit by a justice said the DOJ lacked evidence.
UnitedHealthcare's Medicare and status segment, which includes the Medicare Advantage business, is UnitedHealth Group's largest gross driver, raking successful $139 cardinal successful income past year.
The update successful the probe comes aft a tumultuous past twelvemonth for UnitedHealthcare. Shares of UnitedHealthcare's genitor company, UnitedHealth Group, are down much than 42% for the twelvemonth aft it suspended its 2025 forecast amid skyrocketing aesculapian costs, announced the astonishment exit of Witty and grappled with the reported probes into its Medicare Advantage business.
The company's 2024 wasn't immoderate easier, marked by a historical cyberattack and the torrent of nationalist blowback aft the execution of UnitedHealthcare's CEO, Brian Thompson.
-- CNBC's Bertha Coombs contributed to this report.
English (US) ·